Vaccination Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Vaccination stocks.

Vaccination Stocks Recent News

Date Stock Title
May 15 VBIV VBI Vaccines GAAP EPS of -$0.73 misses by $0.20, revenue of $1.21M misses by $1.64M
May 15 VBIV VBI Vaccines Reports First Quarter 2024 Financial Results
May 15 NVAX 1 Wall Street Analyst Thinks Novavax Stock Is Going to $10. Is It a Sell?
May 15 INO Inovio Pharmaceuticals, Inc. (INO) Presents at 2024 RBC Capital Markets Global Healthcare Conference (Transcript)
May 15 EBS Walgreens launches its own opioid reversal therapy for OTC use
May 15 NVAX 2 Incredible Growth Stocks to Buy Hand Over Fist Right Now
May 15 NVAX Novavax Soars on Sanofi Deal: A Smart Buy or Post-Hype Correction?
May 15 NVAX Novavax Stock Just Tripled. Is It Too Late to Buy?
May 15 NVAX Zacks Investment Ideas feature highlights: GameStop, AMC, Novavax, S&P 500 Index ETF and Nvidia
May 14 INO Inovio Pharmaceuticals, Inc. (INO) The Citizens JMP Life Sciences Conference (Transcript)
May 14 NVAX Novavax, Inc. (NASDAQ:NVAX) Just Reported First-Quarter Earnings And Analysts Are Lifting Their Estimates
May 14 NVAX Zacks Investment Ideas feature highlights: GameStop, AMC, Novavax, Reddit and Tesla
May 14 NVAX Does Soaring Novavax Stock Have Enough Fuel to Climb Higher?
May 14 NVAX Trending tickers: Anglo American, GameStop, Vodafone, Greggs and Novavax
May 14 INO Inovio Pharmaceuticals Inc (INO) Q1 2024 Earnings Call Transcript Highlights: Strategic ...
May 14 INO Inovio Pharmaceuticals (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. (INO) Q1 2024 Earnings Call Transcript
May 13 INO Inovio Pharmaceuticals, Inc. 2024 Q1 - Results - Earnings Call Presentation
May 13 IBIO iBio reports Q3 results
May 13 INO Inovio Pharmaceuticals GAAP EPS of -$1.31 misses by $0.31
Vaccination

Vaccination is the administration of antigenic material (a vaccine) to stimulate an individual's immune system to develop adaptive immunity to a pathogen. Vaccines can prevent or ameliorate infectious disease. When a sufficiently large percentage of a population has been vaccinated, herd immunity results. The effectiveness of vaccination has been widely studied and verified. Vaccination is the most effective method of preventing infectious diseases; widespread immunity due to vaccination is largely responsible for the worldwide eradication of smallpox and the elimination of diseases such as polio, measles, and tetanus from much of the world.
Smallpox was most likely the first disease people tried to prevent by inoculation and was the first disease for which a vaccine was produced. The smallpox vaccine was invented in 1796 by English physician Edward Jenner and although at least six people had used the same principles years earlier he was the first to publish evidence that it was effective and to provide advice on its production. Louis Pasteur furthered the concept through his work in microbiology. The immunization was called vaccination because it was derived from a virus affecting cows (Latin: vacca 'cow'). Smallpox was a contagious and deadly disease, causing the deaths of 20–60% of infected adults and over 80% of infected children. When smallpox was finally eradicated in 1979, it had already killed an estimated 300–500 million people in the 20th century.
In common speech, vaccination and immunization have a similar meaning. This distinguishes it from inoculation, which uses unweakened live pathogens, although in common usage either can refer to an immunization. Vaccination efforts have been met with some controversy on scientific, ethical, political, medical safety, and religious grounds. In rare cases, vaccinations can injure people. In the United States, people may receive compensation for those injuries under the National Vaccine Injury Compensation Program. Early success brought widespread acceptance, and mass vaccination campaigns have greatly reduced the incidence of many diseases in numerous geographic regions.

Browse All Tags